Checkmate Pharmaceuticals, Inc. — Net Income by Fiscal Year
3 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/89635e90-443c-4a53-a19b-efd1fbed0918/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2021 | $-61.4M | 2021-01-01 – 2021-12-31 | evidence 0001193125-22-088386 |
| FY 2020 | $-36.9M | 2020-01-01 – 2020-12-31 | evidence 0001193125-21-098414 |
| FY 2019 | $-28.3M | 2019-01-01 – 2019-12-31 | evidence 0001193125-21-098414 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Checkmate Pharmaceuticals, Inc. — all facts · Operating Income